Budapest, Hungary

Eva E Kiss


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Discovering the Innovative Work of Inventor Eva E. Kiss

Introduction: Eva E. Kiss, a notable inventor based in Budapest, Hungary, has made significant contributions to the field of pharmaceutical compositions. With one registered patent to her name, Eva has focused her innovation on developing stable parenteral compositions that enhance cancer treatment options.

Latest Patents: Eva E. Kiss holds a patent for "Stable parenteral compositions of vinblastine or vincristine." This invention pertains to novel, parenterally useful, stable aqueous pharmaceutical compositions, particularly injectable solutions containing a bis-indole alkaloid. The compositions are comprised of the zinc complex of a bis-indole alkaloid, with vincristine and vinblastine being the primary focus. These solutions also contain a bivalent metal gluconate and a preserving agent dissolved in a mono- or polyhydric alcohol. Furthermore, Eva's patent includes a method for the preparation of these compositions, which are essential for the parenteral administration of bis-indole alkaloids in cancer chemotherapy.

Career Highlights: Eva E. Kiss has played a vital role in the pharmaceutical industry and is associated with Richter Gedeon Vegyeszeti Gyar Rt, a prominent company dedicated to innovative healthcare solutions. Her work reflects a commitment to improving patient outcomes through effective drug formulations.

Collaborations: In her pursuit of innovation, Eva has collaborated with esteemed colleagues such as Maria Gazdag and Gabor Szepesi. Their collective expertise contributes to the advancements made in pharmaceutical compositions and the ongoing research within the company.

Conclusion: As an influential figure in the realm of pharmaceutical inventions, Eva E. Kiss continues to impact the fight against cancer with her patented innovations. Her dedication and collaboration with industry professionals ensure that her work in stable parenteral compositions will play a crucial role in future therapeutic developments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…